1. Home
  2. ATYR vs HELE Comparison

ATYR vs HELE Comparison

Compare ATYR & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • HELE
  • Stock Information
  • Founded
  • ATYR 2005
  • HELE 1968
  • Country
  • ATYR United States
  • HELE United States
  • Employees
  • ATYR N/A
  • HELE N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • HELE Home Furnishings
  • Sector
  • ATYR Health Care
  • HELE Consumer Discretionary
  • Exchange
  • ATYR Nasdaq
  • HELE Nasdaq
  • Market Cap
  • ATYR 451.3M
  • HELE 505.7M
  • IPO Year
  • ATYR 2015
  • HELE N/A
  • Fundamental
  • Price
  • ATYR $5.35
  • HELE $24.11
  • Analyst Decision
  • ATYR Strong Buy
  • HELE Hold
  • Analyst Count
  • ATYR 5
  • HELE 3
  • Target Price
  • ATYR $23.25
  • HELE $44.33
  • AVG Volume (30 Days)
  • ATYR 5.0M
  • HELE 611.0K
  • Earning Date
  • ATYR 08-07-2025
  • HELE 10-08-2025
  • Dividend Yield
  • ATYR N/A
  • HELE N/A
  • EPS Growth
  • ATYR N/A
  • HELE N/A
  • EPS
  • ATYR N/A
  • HELE N/A
  • Revenue
  • ATYR N/A
  • HELE $1,862,473,000.00
  • Revenue This Year
  • ATYR $478.72
  • HELE N/A
  • Revenue Next Year
  • ATYR $1,899.26
  • HELE $1.70
  • P/E Ratio
  • ATYR N/A
  • HELE N/A
  • Revenue Growth
  • ATYR N/A
  • HELE N/A
  • 52 Week Low
  • ATYR $1.67
  • HELE $20.02
  • 52 Week High
  • ATYR $7.29
  • HELE $77.95
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 52.99
  • HELE 52.15
  • Support Level
  • ATYR $4.58
  • HELE $23.10
  • Resistance Level
  • ATYR $5.03
  • HELE $24.50
  • Average True Range (ATR)
  • ATYR 0.34
  • HELE 1.03
  • MACD
  • ATYR -0.01
  • HELE 0.32
  • Stochastic Oscillator
  • ATYR 66.09
  • HELE 87.21

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: